A 40-year-old Aboriginal woman from a remote community has a history of definite acute rheumatic fever at age 13 years with mild rheumatic mitral regurgitation. She has been adherent to secondary prophylaxis. According to the current Australian rheumatic heart disease guideline, what is the standard secondary prophylaxis regimen to prevent recurrent acute rheumatic fever?